21 May 2013
Keywords: gsk, diversify, yet, derisk, says, new, ceo
Article | 23 June 2008
The UK's leading drug major, GlaxoSmithKline, will broaden the range of its focus from pharmaceuticals while reducing the risk of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 June 2008
20 May 2013
© 2013 thepharmaletter.com